References
- BennettJLStüveOUpdate on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implicationsClin Neuropharmacol200932312113219483479
- HauserSLOksenbergJRThe neurobiology of multiple sclerosis: genes, inflammation, and neurodegenerationNeuron2006521617617015227
- LublinFDReingoldSCDefining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple SclerosisNeurology19964649079118780061
- HartungHPHigh-dose, high-frequency recombinant interferon beta-1a in the treatment of multiple sclerosisExpert Opin Pharmacother200910229130919236200
- World Health OrganizationAdherence to Long-Term Therapies: Evidence for ActionGenevaWorld Health Organization2003 Available from: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdfAccessed March 22, 2013
- RíoJPorcelJTéllezNFactors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosisMult Scler200511330630915957512
- O’RourkeKEHutchinsonMStopping beta-interferon therapy in multiple sclerosis: an analysis of stopping patternsMult Scler2005111465015732266
- CoxDStoneJManaging self-injection difficulties in patients with relapsing-remitting multiple sclerosisJ Neurosci Nurs200638316717116817668
- TanHCaiQAgarwalSStephensonJJKamatSImpact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosisAdv Ther2011281516121153000
- LugaresiAAddressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?Expert Opin Drug Deliv200969995100219637982
- Rebif Summary of Product Characteristics [webpage on the Internet]UKDatapharm Communications, Ltd2013 Available from http://www.medicines.org.uk/EMC/medicine/22392/SPC/Rebifsolutionforinjectioninpre-filledsyringes/Accessed March 22, 2013
- HeerenTD’AgostinoRRobustness of the two independent samples t-test when applied to ordinal scaled dataStat Med19876179903576020
- TremlettHLOgerJInterrupted therapy: stopping and switching of the beta-interferons prescribed for MSNeurology200361455155412939437
- BoggildMPalaceJBartonPMultiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparatorBMJ2009339b467719955128
- http://www.abpi.org.uk/Pages/default.aspx[homepage on the Internet]. Association of the British Pharmaceutical IndustryDemonstrating Value with Real World Data2011The Association of the British Pharmaceutical Industry2011 Available from: http://www.abpi.org.uk/our-work/library/guidelines/Pages/real-world-data.aspxAccessed March 22, 2013
- RothwellPMMcDowellZWongCKDormanPJDoctors and patients don’t agree: cross sectional study of patients’ and doctors’ perceptions and assessments of disability in multiple sclerosisBMJ19973147094158015839169401
- RiñonABuchMHolleyDVerdunEThe MS Choices Survey: findings of a study assessing physician and patient perspectives on living with and managing multiple sclerosisPatient Prefer Adherence2011562964322259240
- ExellSVerdunEDriebergenRA new electronic device for subcutaneous injection of IFN-β-1aExpert Rev Med Devices20118554355321728909
- GiovannoniGBarbarashOCasset-SemanazFRebif New Formulation Study GroupSafety and immunogenicity of a new formulation of interferon β-1a (Rebif® New Formulation) in a phase IIIb study in patients with relapsing multiple sclerosis: 96-week resultsMult Scler20091521922818755819
- BeerKMüllerMHew-WinzelerAMThe prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational studyBMC Neurol20111114422074056
- MesarošSStojsavljevićNDujmović-BašuroskiIDejanovićIPekmezovićTDrulovićJLong-term adherence to interferon-beta treatment in a cohort of RRMS patients in Belgrade, SerbiaClin Neurol Neurosurg201211481145114822425462
- Vicente IturbeCAra CallizoJRHuarte LacunzaRNavarro AznárezHSerrano MislataNRabanaque HernándezMJDiscontinuation and long-term adherence to beta interferon therapy in patients with multiple sclerosisFarm Hosp20123627783 Spanish21820930